Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

Haleon-owned over-the-counter pain medication Panadol is making an effort to be more inclusive in its messaging.

On Sunday, Haleon PLC – ADR (HLN) stock saw a decline, ending the day at $9.47 which represents a decrease of $-0.10 or -1.04% from the prior close of $9.57. The stock opened at $9.37 and touched a ...

Based in the United Kingdom, Haleon makes consumer health care products, including Advil, Centrum Multivitamin and Aquafresh ...

Barclays analyst Iain Simpson maintained a Buy rating on Haleon PLC (HLN – Research Report) today and set a price target of £4.15. The ...

PFG Investments LLC trimmed its position in Haleon plc (NYSE:HLN – Free Report) by 11.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The ...

The consumer health company site will launch an internship program with the state government and Virginia Commonwealth ...

Richmond is cementing its status as a hub for pharmaceutical innovation, with Gov. Glenn Youngkin dubbing the region a ...

Haleon, a global company behind home healthcare products like Advil, Tums and Aquafresh, announced plans to upgrade its Richmond research and development facility.

Haleon PLC closed 5.73% below its 52-week high of £4.01, which the company reached on September 18th.

Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre ...

(Reuters) - Consumer healthcare company Haleon said on Wednesday it will invest $54 million in its global research and development centre in Richmond, U.S., aiming to boost its pipeline for new ...